A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer-Reference-Cited by-同舟云学术

A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer

Published:2012-02 Issue:2 Volume:124 Page:205-209
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Sehouli Jalid,Alvarez Ana Maria,Manouchehrpour Shokoufeh,Ghatage Prafull,Szczylik Cezary,Zimmermann Annamaria,Bauknecht Thomas,Look Katherine Y.,Oskay-Öezcelik Gultan

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference21 articles.

1. Global Cancer Facts & Figures 2007;American Cancer Society,2007

2. Focus on epithelial ovarian cancer;Ozols;Cancer Cell,2004

3. Management of platinum-sensitive recurrent ovarian cancer;Pfisterer;Semin Oncol,2006

4. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;Parmar;Lancet,2003

5. Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer;Baldwin;Drugs,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of cisplatin resistance in ovarian cancer;Genes & Diseases;2023-08

2. Platinum-Pemetrexed Chemotherapy for Recurrent Ovarian Cancer (ROC): A Single Center Experience;Cancer Investigation;2021-09-06

3. Molecular Mechanism and Role of Translational Values of Heat Shock Protein (HSP27) in Various Disease;Journal of Pharmaceutical Research International;2020-10-19

4. Association between EPHX1 polymorphism rs1051740 and the risk of ovarian cancer: a meta-analysis;Artificial Cells, Nanomedicine, and Biotechnology;2019-06-07

5. The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review;Oncology Reviews;2018-03-21